Exploratory metabolomics of metabolic syndrome: A status report
|
摘要
Metabolic syndrome(MetS) is as a cluster of cardio-metabolic factors that greatly increase the risk of chronic diseases such as type II diabetes mellitus and atherosclerotic cardiovascular disease. In the United States, obesity, physical inactivity, aging, and genetics(to a minor extent) have arisen as risk factors for developing MetS. Although 35% of American adults suffer from MetS, its pathogenesis largely remains unknown. Worse, there is a lack of screening and optimum therapy for this disease. Researchers have consequently turned towards metabolomics to identify biomarkers to better understand MetS. The purpose of this review is to characterize various metabolites and their potential connections to MetS. Numerous studies have also characterized MetS as a disease of increased inflammation, and therefore this review also explores how metabolites play a role in various inflammatory pathways. Our review explores a broad range of metabolites including biogenic amines, branched chain amino acids, aromatic amines, phosphatidylcholines, as well as a variety of other molecules. We will explore their biochemical pathways and their potential role in serving as biomarkers.
Metabolic syndrome(MetS) is as a cluster of cardio-metabolic factors that greatly increase the risk of chronic diseases such as type II diabetes mellitus and atherosclerotic cardiovascular disease. In the United States, obesity, physical inactivity, aging, and genetics(to a minor extent) have arisen as risk factors for developing MetS. Although 35% of American adults suffer from MetS, its pathogenesis largely remains unknown. Worse, there is a lack of screening and optimum therapy for this disease. Researchers have consequently turned towards metabolomics to identify biomarkers to better understand MetS. The purpose of this review is to characterize various metabolites and their potential connections to MetS. Numerous studies have also characterized MetS as a disease of increased inflammation, and therefore this review also explores how metabolites play a role in various inflammatory pathways. Our review explores a broad range of metabolites including biogenic amines, branched chain amino acids, aromatic amines, phosphatidylcholines, as well as a variety of other molecules. We will explore their biochemical pathways and their potential role in serving as biomarkers.
Metabolic syndrome(MetS) is as a cluster of cardio-metabolic factors that greatly increase the risk of chronic diseases such as type II diabetes mellitus and atherosclerotic cardiovascular disease. In the United States, obesity, physical inactivity, aging, and genetics(to a minor extent) have arisen as risk factors for developing MetS. Although 35% of American adults suffer from MetS, its pathogenesis largely remains unknown. Worse, there is a lack of screening and optimum therapy for this disease. Researchers have consequently turned towards metabolomics to identify biomarkers to better understand MetS. The purpose of this review is to characterize various metabolites and their potential connections to MetS. Numerous studies have also characterized MetS as a disease of increased inflammation, and therefore this review also explores how metabolites play a role in various inflammatory pathways. Our review explores a broad range of metabolites including biogenic amines, branched chain amino acids, aromatic amines, phosphatidylcholines, as well as a variety of other molecules. We will explore their biochemical pathways and their potential role in serving as biomarkers.
引文
1 Alberti KG,Eckel RH,Grundy SM,Zimmet PZ,Cleeman JI,Donato KA,Fruchart JC,James WP,Loria CM,Smith SC;International Diabetes Federation Task Force on Epidemiology and Prevention;Hational Heart,Lung,and Blood Institute;American Heart Association;World Heart Federation;International Atherosclerosis Society;International Association for the Study of Obesity.Harmonizing the metabolic syndrome:A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart,Lung,and Blood Institute;American Heart Association;World Heart Federation;International Atherosclerosis Society;and International Association for the Study of Obesity.Circulation 2009;120:1640-1645[PMID:19805654 DOI:10.1161/CIRCULATIONAHA.109.192644]
2 Ntzouvani A,Nomikos T,Panagiotakos D,Fragopoulou E,Pitsavos C,McCann A,Ueland PM,Antonopoulou S.Amino acid profile and metabolic syndrome in a male Mediterranean population:A cross-sectional study.Nutr Metab Cardiovasc Dis 2017;27:1021-1030[PMID:28958693 DOI:10.1016/j.numecd.2017.07.006]
3 Jialal I,Devaraj S,Rajamani U.Dysregulation of monocyte biology in metabolic syndrome.Expert Rev Endocrinol Metab 2014;9:213-221[DOI:10.1586/17446651.2014.890046]
4 Ramakrishanan N,Denna T,Devaraj S,Adams-Huet B,Jialal I.Exploratory lipidomics in patients with nascent Metabolic Syndrome.J Diabetes Complications 2018;32:791-794[PMID:29895440 DOI:10.1016/j.jdiacomp.2018.05.014]
5 Reddy P,Leong J,Jialal I.Amino acid levels in nascent metabolic syndrome:A contributor to the pro-inflammatory burden.J Diabetes Complications 2018;32:465-469[PMID:29559272 DOI:10.1016/j.jdiacomp.2018.02.005]
6 Lent-Schochet D,Silva R,McLaughlin M,Huet B,Jialal I.Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome.Horm Mol Biol Clin Investig 2018;35[PMID:29668463 DOI:10.1515/hmbci-2018-0015]
7 Velasquez MT,Ramezani A,Manal A,Raj DS.Trimethylamine N-Oxide:The Good,the Bad and the Unknown.Toxins(Basel)2016;8:pii:E326[PMID:27834801 DOI:10.3390/toxins8110326]
8 Kanitsoraphan C,Rattanawong P,Charoensri S,Senthong V.Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.Curr Nutr Rep 2018;7:207-213[PMID:30362023 DOI:10.1007/s13668-018-0252-z]
9 Schugar RC,Shih DM,Warrier M,Helsley RN,Burrows A,Ferguson D,Brown AL,Gromovsky AD,Heine M,Chatterjee A,Li L,Li XS,Wang Z,Willard B,Meng Y,Kim H,Che N,Pan C,Lee RG,Crooke RM,Graham MJ,Morton RE,Langefeld CD,Das SK,Rudel LL,Zein N,McCullough AJ,Dasarathy S,Tang WHW,Erokwu BO,Flask CA,Laakso M,Civelek M,Naga Prasad SV,Heeren J,Lusis AJ,Hazen SL,Brown JM.The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Cell Rep 2017;19:2451-2461[PMID:28636934 DOI:10.1016/j.celrep.2017.05.077]
10 Detopoulou P,Panagiotakos DB,Antonopoulou S,Pitsavos C,Stefanadis C.Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults:the ATTICA study.Am J Clin Nutr 2008;87:424-430[PMID:18258634 DOI:10.1093/ajcn/87.2.424]
11 Konstantinova SV,Tell GS,Vollset SE,Nyg?rd O,Bleie?,Ueland PM.Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women.J Nutr 2008;138:914-920[PMID:18424601 DOI:10.1093/jn/138.5.914]
12 Raubenheimer PJ,Nyirenda MJ,Walker BR.A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet.Diabetes 2006;55:2015-2020[PMID:16804070 DOI:10.2337/db06-0097]
13 Gao X,Wang Y,Sun G.High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population.Nutrition 2017;33:28-34[PMID:27908547 DOI:10.1016/j.nut.2016.08.005]
14 Roe AJ,Zhang S,Bhadelia RA,Johnson EJ,Lichtenstein AH,Rogers GT,Rosenberg IH,Smith CE,Zeisel SH,Scott TM.Choline and its metabolites are differently associated with cardiometabolic risk factors,history of cardiovascular disease,and MRI-documented cerebrovascular disease in older adults.Am J Clin Nutr 2017;105:1283-1290[PMID:28356272DOI:10.3945/ajcn.116.137158]
15 Panchal SK,Poudyal H,Ward LC,Waanders J,Brown L.Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats.Food Funct 2015;6:2496-2506[PMID:26190559 DOI:10.1039/c5fo00480b]
16 Lee BJ,Lin JS,Lin YC,Lin PT.Antiinflammatory effects of L-carnitine supplementation(1000mg/d)in coronary artery disease patients.Nutrition 2015;31:475-479[PMID:25701337 DOI:10.1016/j.nut.2014.10.001]
17 Johri AM,Heyland DK,Hétu MF,Crawford B,Spence JD.Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease:evidence and controversies.Nutr Metab Cardiovasc Dis 2014;24:808-814[PMID:24837277 DOI:10.1016/j.numecd.2014.03.007]
18 Auinger A,Rubin D,Sabandal M,Helwig U,Rüther A,Schreiber S,Foelsch UR,D?ring F,Schrezenmeir J.A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome.Br J Nutr 2013;109:810-815[PMID:22809552 DOI:10.1017/S0007114512002656]
19 Cuturic M,Abramson RK,Breen RJ,Edwards AC,Levy EE.Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia:A cross-sectional study.World J Biol Psychiatry 2016;17:475-479[PMID:27088656 DOI:10.1080/15622975.2016.1178803]
20 Festi D,Schiumerini R,Eusebi LH,Marasco G,Taddia M,Colecchia A.Gut microbiota and metabolic syndrome.World J Gastroenterol 2014;20:16079-16094[PMID:25473159 DOI:10.3748/wjg.v20.i43.16079]
21 Tang WH,Hazen SL.Microbiome,trimethylamine N-oxide,and cardiometabolic disease.Transl Res 2017;179:108-115[PMID:27490453 DOI:10.1016/j.trsl.2016.07.007]
22 Mueller DM,Allenspach M,Othman A,Saely CH,Muendlein A,Vonbank A,Drexel H,von Eckardstein A.Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.Atherosclerosis 2015;243:638-644[PMID:26554714 DOI:10.1016/j.atherosclerosis.2015.10.091]
23 Tr?seid M,Hov JR,Nestvold TK,Thoresen H,Berge RK,Svardal A,Lappeg?rd KT.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.Metab Syndr Relat Disord 2016;14:197-201[PMID:27081744 DOI:10.1089/met.2015.0120]
24 Barrea L,Annunziata G,Muscogiuri G,Di Somma C,Laudisio D,Maisto M,de Alteriis G,Tenore GC,Colao A,Savastano S.Trimethylamine-N-oxide(TMAO)as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome.Nutrients 2018;10:pii:E1971[PMID:30551613 DOI:10.3390/nu10121971]
25 Seldin MM,Meng Y,Qi H,Zhu W,Wang Z,Hazen SL,Lusis AJ,Shih DM.Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.J Am Heart Assoc 2016;5:pii:e002767[PMID:26903003 DOI:10.1161/JAHA.115.002767]
26 Sookoian S,Pirola CJ.Alanine and aspartate aminotransferase and glutamine-cycling pathway:their roles in pathogenesis of metabolic syndrome.World J Gastroenterol 2012;18:3775-3781[PMID:22876026 DOI:10.3748/wjg.v18.i29.3775]
27 Schindhelm RK,Dekker JM,Nijpels G,Stehouwer CD,Bouter LM,Heine RJ,Diamant M.Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women:the Hoorn Study.Diabet Med 2007;24:430-435[PMID:17388959 DOI:10.1111/j.1464-5491.2007.02100.x]
28 Olynyk JK,Knuiman MW,Divitini ML,Davis TM,Beilby J,Hung J.Serum alanine aminotransferase,metabolic syndrome,and cardiovascular disease in an Australian population.Am J Gastroenterol 2009;104:1715-1722[PMID:19491832 DOI:10.1038/ajg.2009.229]
29 Gonzalez-Franquesa A,Burkart AM,Isganaitis E,Patti ME.What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?Curr Diab Rep 2016;16:74[PMID:27319324 DOI:10.1007/s11892-016-0763-1]
30 Pallares-Méndez R,Aguilar-Salinas CA,Cruz-Bautista I,Del Bosque-Plata L.Metabolomics in diabetes,a review.Ann Med 2016;48:89-102[PMID:26883715 DOI:10.3109/07853890.2015.1137630]
31 Yamada J,Tomiyama H,Yambe M,Koji Y,Motobe K,Shiina K,Yamamoto Y,Yamashina A.Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.Atherosclerosis2006;189:198-205[PMID:16405892 DOI:10.1016/j.atherosclerosis.2005.11.036]
32 Cheng S,Rhee EP,Larson MG,Lewis GD,McCabe EL,Shen D,Palma MJ,Roberts LD,Dejam A,Souza AL,Deik AA,Magnusson M,Fox CS,O'Donnell CJ,Vasan RS,Melander O,Clish CB,Gerszten RE,Wang TJ.Metabolite profiling identifies pathways associated with metabolic risk in humans.Circulation 2012;125:2222-2231[PMID:22496159 DOI:10.1161/CIRCULATIONAHA.111.067827]
33 Wang TJ,Larson MG,Vasan RS,Cheng S,Rhee EP,McCabe E,Lewis GD,Fox CS,Jacques PF,Fernandez C,O'Donnell CJ,Carr SA,Mootha VK,Florez JC,Souza A,Melander O,Clish CB,Gerszten RE.Metabolite profiles and the risk of developing diabetes.Nat Med 2011;17:448-453[PMID:21423183 DOI:10.1038/nm.2307]
34 Wang S,Yu X,Zhang W,Ji F,Wang M,Yang R,Li H,Chen W,Dong J.Association of serum metabolites with impaired fasting glucose/diabetes and traditional risk factors for metabolic disease in Chinese adults.Clin Chim Acta 2018;487:60-65[PMID:30237081 DOI:10.1016/j.cca.2018.09.028]
35 Co?ffier M,Marion R,Leplingard A,Lerebours E,DucrottéP,Déchelotte P.Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e(2)production by human gut in-vitro.Cytokine 2002;18:92-97[PMID:12096924 DOI:10.1006/cyto.2002.1027]
36 Tulipani S,Palau-Rodriguez M,Mi?arro Alonso A,Cardona F,Marco-Ramell A,Zonja B,Lopez de Alda M,Mu?oz-Garach A,Sanchez-Pla A,Tinahones FJ,Andres-Lacueva C.Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes.Clin Chim Acta 2016;463:53-61[PMID:27720726 DOI:10.1016/j.cca.2016.10.005]
37 Newgard CB,An J,Bain JR,Muehlbauer MJ,Stevens RD,Lien LF,Haqq AM,Shah SH,Arlotto M,Slentz CA,Rochon J,Gallup D,Ilkayeva O,Wenner BR,Yancy WS,Eisenson H,Musante G,Surwit RS,Millington DS,Butler MD,Svetkey LP.A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.Cell Metab 2009;9:311-326[PMID:19356713 DOI:10.1016/j.cmet.2009.02.002]
38 RoyChoudhury S,Mishra BP,Khan T,Chattopadhayay R,Lodh I,Datta Ray C,Bose G,Sarkar HS,Srivastava S,Joshi MV,Chakravarty B,Chaudhury K.Serum metabolomics of Indian women with polycystic ovary syndrome using 1H NMR coupled with a pattern recognition approach.Mol Biosyst 2016;12:3407-3416[PMID:27714060 DOI:10.1039/c6mb00420b]
39 Shim K,Gulhar R,Jialal I.Exploratory Metabolomics of Nascent Metabolic Syndrome.J Diabetes Complications 2018;In press[DOI:10.1016/j.jdiacomp.2018.12.002]
40 Monti LD,Casiraghi MC,Setola E,Galluccio E,Pagani MA,Quaglia L,Bosi E,Piatti P.L-arginine enriched biscuits improve endothelial function and glucose metabolism:a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome.Metabolism 2013;62:255-264[PMID:23040413 DOI:10.1016/j.metabol.2012.08.004]
41 Deveaux A,Pham I,West SG,AndréE,Lantoine-Adam F,Bunouf P,Sadi S,Hermier D,MathéV,Fouillet H,Huneau JF,Benamouzig R,Mariotti F.l-Arginine Supplementation Alleviates Postprandial Endothelial Dysfunction When Baseline Fasting Plasma Arginine Concentration Is Low:A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors.J Nutr 2016;146:1330-1340[PMID:27281800 DOI:10.3945/jn.115.227959]
42 Kawano T,Nomura M,Nisikado A,Nakaya Y,Ito S.Supplementation of L-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats.Life Sci 2003;73:3017-3026[PMID:14519450 DOI:10.1016/j.lfs.2003.06.004]
43 Korish AA.Multiple antioxidants and L-arginine modulate inflammation and dyslipidemia in chronic renal failure rats.Ren Fail 2010;32:203-213[PMID:20199183 DOI:10.3109/08860221003592820]
44 Lucotti P,Monti L,Setola E,La Canna G,Castiglioni A,Rossodivita A,Pala MG,Formica F,Paolini G,Catapano AL,Bosi E,Alfieri O,Piatti P.Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.Metabolism 2009;58:1270-1276[PMID:19592054 DOI:10.1016/j.metabol.2009.03.029]
45 Lucotti P,Setola E,Monti LD,Galluccio E,Costa S,Sandoli EP,Fermo I,Rabaiotti G,Gatti R,Piatti P.Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese,insulin-resistant type 2 diabetic patients.Am J Physiol Endocrinol Metab 2006;291:E906-E912[PMID:16772327 DOI:10.1152/ajpendo.00002.2006]
46 Konukoglu D,Firtina S,Serin O.The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal,impaired,and diabetic glucose tolerance.Metabolism 2008;57:110-115[PMID:18078867 DOI:10.1016/j.metabol.2007.08.013]
47 Ganz T,Wainstein J,Gilad S,Limor R,Boaz M,Stern N.Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.Diabetes Metab Res Rev 2017;33[PMID:27393712 DOI:10.1002/dmrr.2836]
48 Du S,Sun S,Liu L,Zhang Q,Guo F,Li C,Feng R,Sun C.Effects of Histidine Supplementation on Global Serum and Urine 1H NMR-based Metabolomics and Serum Amino Acid Profiles in Obese Women from a Randomized Controlled Study.J Proteome Res 2017;16:2221-2230[PMID:28447460 DOI:10.1021/acs.jproteome.7b00030]
49 Mong MC,Chao CY,Yin MC.Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet.Eur J Pharmacol 2011;653:82-88[PMID:21167151 DOI:10.1016/j.ejphar.2010.12.001]
50 Hasegawa S,Ichiyama T,Sonaka I,Ohsaki A,Okada S,Wakiguchi H,Kudo K,Kittaka S,Hara M,Furukawa S.Cysteine,histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells.Clin Exp Immunol 2012;167:269-274[PMID:22236003 DOI:10.1111/j.1365-2249.2011.04519.x]
51 Watanabe M,Suliman ME,Qureshi AR,Garcia-Lopez E,Bárány P,Heimbürger O,Stenvinkel P,Lindholm B.Consequences of low plasma histidine in chronic kidney disease patients:associations with inflammation,oxidative stress,and mortality.Am J Clin Nutr 2008;87:1860-1866[PMID:18541578 DOI:10.1093/ajcn/87.6.1860]
52 Gralka E,Luchinat C,Tenori L,Ernst B,Thurnheer M,Schultes B.Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner.Am J Clin Nutr 2015;102:1313-1322[PMID:26581381 DOI:10.3945/ajcn.115.110536]
53 Feng RN,Niu YC,Sun XW,Li Q,Zhao C,Wang C,Guo FC,Sun CH,Li Y.Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome:a randomised controlled trial.Diabetologia 2013;56:985-994[PMID:23361591 DOI:10.1007/s00125-013-2839-7]
54 Han N,Chae JW,Jeon J,Lee J,Back HM,Song B,Kwon KI,Kim SK,Yun HY.Prediction of Methionine and Homocysteine levels in Zucker diabetic fatty(ZDF)rats as a T2DM animal model after consumption of a Methionine-rich diet.Nutr Metab(Lond)2018;15:14[PMID:29449868 DOI:10.1186/s12986-018-0247-1]
55 Adams SH.Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.Adv Nutr 2011;2:445-456[PMID:22332087 DOI:10.3945/an.111.000737]
56 Bene J,Márton M,Mohás M,Bagosi Z,Bujtor Z,Oroszlán T,Gasztonyi B,Wittmann I,Melegh B.Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome.Ann Nutr Metab 2013;62:80-85[PMID:23296094 DOI:10.1159/000345759]
57 Bremer AA,Mietus-Snyder M,Lustig RH.Toward a unifying hypothesis of metabolic syndrome.Pediatrics 2012;129:557-570[PMID:22351884 DOI:10.1542/peds.2011-2912]
58 Mohorko N,Petelin A,Jurdana M,Biolo G,Jenko-Pra?nikar Z.Elevated serum levels of cysteine and tyrosine:early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome.Biomed Res Int 2015;2015:418681[PMID:25821801 DOI:10.1155/2015/418681]
59 Elshorbagy AK,Valdivia-Garcia M,Refsum H,Butte N.The Association of Cysteine with Obesity,Inflammatory Cytokines and Insulin Resistance in Hispanic Children and Adolescents.PloS One 2012;7:e44166[PMID:22984471 DOI:10.1371/journal.pone.0044166]
60 Martínez Y,Li X,Liu G,Bin P,Yan W,Más D,ValdiviéM,Hu CA,Ren W,Yin Y.The role of methionine on metabolism,oxidative stress,and diseases.Amino Acids 2017;49:2091-2098[PMID:28929442 DOI:10.1007/s00726-017-2494-2]
61 Iida M,Harada S,Kurihara A,Fukai K,Kuwabara K,Sugiyama D,Takeuchi A,Okamura T,Akiyama M,Nishiwaki Y,Suzuki A,Hirayama A,Sugimoto M,Soga T,Tomita M,Banno K,Aoki D,Takebayashi T.Profiling of plasma metabolites in postmenopausal women with metabolic syndrome.Menopause 2016;23:749-758[PMID:27070805 DOI:10.1097/GME.0000000000000630]
62 Iyer A,Fairlie DP,Brown L.Lysine acetylation in obesity,diabetes and metabolic disease.Immunol Cell Biol 2012;90:39-46[PMID:22083525 DOI:10.1038/icb.2011.99]
63 Messina V.Nutritional and health benefits of dried beans.Am J Clin Nutr 2014;100 Suppl 1:437S-442S[PMID:24871476 DOI:10.3945/ajcn.113.071472]
64 Hart LM,Vogelzangs N,Mook-Kanamori DO,Brahimaj A,Nano J,van der Heijden AAWA,Willems van Dijk K,Slieker RC,Steyerberg EW,Ikram MA,Beekman M,Boomsma DI,van Duijn CM,Slagboom PE,Stehouwer CDA,Schalkwijk CG,Arts ICW,Dekker JM,Dehghan A,Muka T,van der Kallen CJH,Nijpels G,van Greevenbroek MMJ.Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes.J Clin Endocrinol Metab 2018;103:4569-4579[PMID:30113659 DOI:10.1210/jc.2018-01165]
65 Cole LK,Vance JE,Vance DE.Phosphatidylcholine biosynthesis and lipoprotein metabolism.Biochim Biophys Acta 2012;1821:754-761[PMID:21979151 DOI:10.1016/j.bbalip.2011.09.009]
66 Burrill JS,Long EK,Reilly B,Deng Y,Armitage IM,Scherer PE,Bernlohr DA.Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes.Mol Endocrinol 2015;29:411-420[PMID:25635940 DOI:10.1210/me.2014-1275]
67 Riddle ES,Roman H,Ahsan M,Shin H,Thalacker-Mercer A.Leucine in the Presence of Inflammation Alters BCAA Metabolism in Human Myotubes.FASEB J 2016;30:Abstract 430.7
68 Fiehn O,Garvey WT,Newman JW,Lok KH,Hoppel CL,Adams SH.Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese AfricanAmerican women.PLoS One 2010;5:e15234[PMID:21170321 DOI:10.1371/journal.pone.0015234]
69 Hu W,Sun L,Gong Y,Zhou Y,Yang P,Ye Z,Fu J,Huang A,Fu Z,Yu W,Zhao Y,Yang T,Zhou H.Relationship between Branched-Chain Amino Acids,Metabolic Syndrome,and Cardiovascular Risk Profile in a Chinese Population:A Cross-Sectional Study.Int J Endocrinol2016;2016:8173905[PMID:27528871 DOI:10.1155/2016/8173905]
70 Newgard CB.Interplay between lipids and branched-chain amino acids in development of insulin resistance.Cell Metab 2012;15:606-614[PMID:22560213 DOI:10.1016/j.cmet.2012.01.024]
71 Libert DM,Nowacki AS,Natowicz MR.Metabolomic analysis of obesity,metabolic syndrome,and type 2 diabetes:amino acid and acylcarnitine levels change along a spectrum of metabolic wellness.PeerJ 2018;6:e5410[PMID:30186675 DOI:10.7717/peerj.5410]
72 Würtz P,Soininen P,Kangas AJ,R?nnemaa T,Lehtim?ki T,K?h?nen M,Viikari JS,Raitakari OT,Ala-Korpela M.Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults.Diabetes Care 2013;36:648-655[PMID:23129134 DOI:10.2337/dc12-0895]
73 Wijekoon EP,Skinner C,Brosnan ME,Brosnan JT.Amino acid metabolism in the Zucker diabetic fatty rat:effects of insulin resistance and of type 2 diabetes.Can J Physiol Pharmacol 2004;82:506-514[PMID:15389298 DOI:10.1139/y04-067]
74 Chen T,Zheng X,Ma X,Bao Y,Ni Y,Hu C,Rajani C,Huang F,Zhao A,Jia W,Jia W.Tryptophan Predicts the Risk for Future Type 2 Diabetes.PLoS One 2016;11:e0162192[PMID:27598004 DOI:10.1371/journal.pone.0162192]
75 Oxenkrug G,van der Hart M,Summergrad P.Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus.Integr Mol Med 2015;2:365-368[PMID:26523229 DOI:10.15761/IMM.1000169]
76 Reginaldo C,Jacques P,Scott T,Oxenkrug G,Selhub J,Paul L.Xanthurenic acid is associated with higher insulin resistance and higher odds of diabetes.FASEB J 2015;29:Abstract 919.20
77 Cervenka I,Agudelo LZ,Ruas JL.Kynurenines:Tryptophan's metabolites in exercise,inflammation,and mental health.Science 2017;357:pii:eaaf9794[PMID:28751584 DOI:10.1126/science.aaf9794]
78 Weinberg JM.Lipotoxicity.Kidney Int 2006;70:1560-1566[PMID:16955100 DOI:10.1038/sj.ki.5001834]
79 Suvitaival T,Bondia-Pons I,Yetukuri L,P?h?P,Nolan JJ,Hy?tyl?inen T,Kuusisto J,Ore?i?M.Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.Metabolism 2018;78:1-12[PMID:28941595 DOI:10.1016/j.metabol.2017.08.014]
80 Alshehry ZH,Mundra PA,Barlow CK,Mellett NA,Wong G,McConville MJ,Simes J,Tonkin AM,Sullivan DR,Barnes EH,Nestel PJ,Kingwell BA,Marre M,Neal B,Poulter NR,Rodgers A,Williams B,Zoungas S,Hillis GS,Chalmers J,Woodward M,Meikle PJ.Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type2 Diabetes Mellitus.Circulation 2016;134:1637-1650[PMID:27756783 DOI:10.1161/CIRCULA-TIONAHA.116.023233]
81 Pujos-Guillot E,Brandolini M,Pétéra M,Grissa D,Joly C,Lyan B,Herqueloté,Czernichow S,Zins M,Goldberg M,Comte B.Systems Metabolomics for Prediction of Metabolic Syndrome.JProteome Res 2017;16:2262-2272[PMID:28440083 DOI:10.1021/acs.jproteome.7b00116]
2 Ntzouvani A,Nomikos T,Panagiotakos D,Fragopoulou E,Pitsavos C,McCann A,Ueland PM,Antonopoulou S.Amino acid profile and metabolic syndrome in a male Mediterranean population:A cross-sectional study.Nutr Metab Cardiovasc Dis 2017;27:1021-1030[PMID:28958693 DOI:10.1016/j.numecd.2017.07.006]
3 Jialal I,Devaraj S,Rajamani U.Dysregulation of monocyte biology in metabolic syndrome.Expert Rev Endocrinol Metab 2014;9:213-221[DOI:10.1586/17446651.2014.890046]
4 Ramakrishanan N,Denna T,Devaraj S,Adams-Huet B,Jialal I.Exploratory lipidomics in patients with nascent Metabolic Syndrome.J Diabetes Complications 2018;32:791-794[PMID:29895440 DOI:10.1016/j.jdiacomp.2018.05.014]
5 Reddy P,Leong J,Jialal I.Amino acid levels in nascent metabolic syndrome:A contributor to the pro-inflammatory burden.J Diabetes Complications 2018;32:465-469[PMID:29559272 DOI:10.1016/j.jdiacomp.2018.02.005]
6 Lent-Schochet D,Silva R,McLaughlin M,Huet B,Jialal I.Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome.Horm Mol Biol Clin Investig 2018;35[PMID:29668463 DOI:10.1515/hmbci-2018-0015]
7 Velasquez MT,Ramezani A,Manal A,Raj DS.Trimethylamine N-Oxide:The Good,the Bad and the Unknown.Toxins(Basel)2016;8:pii:E326[PMID:27834801 DOI:10.3390/toxins8110326]
8 Kanitsoraphan C,Rattanawong P,Charoensri S,Senthong V.Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.Curr Nutr Rep 2018;7:207-213[PMID:30362023 DOI:10.1007/s13668-018-0252-z]
9 Schugar RC,Shih DM,Warrier M,Helsley RN,Burrows A,Ferguson D,Brown AL,Gromovsky AD,Heine M,Chatterjee A,Li L,Li XS,Wang Z,Willard B,Meng Y,Kim H,Che N,Pan C,Lee RG,Crooke RM,Graham MJ,Morton RE,Langefeld CD,Das SK,Rudel LL,Zein N,McCullough AJ,Dasarathy S,Tang WHW,Erokwu BO,Flask CA,Laakso M,Civelek M,Naga Prasad SV,Heeren J,Lusis AJ,Hazen SL,Brown JM.The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Cell Rep 2017;19:2451-2461[PMID:28636934 DOI:10.1016/j.celrep.2017.05.077]
10 Detopoulou P,Panagiotakos DB,Antonopoulou S,Pitsavos C,Stefanadis C.Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults:the ATTICA study.Am J Clin Nutr 2008;87:424-430[PMID:18258634 DOI:10.1093/ajcn/87.2.424]
11 Konstantinova SV,Tell GS,Vollset SE,Nyg?rd O,Bleie?,Ueland PM.Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women.J Nutr 2008;138:914-920[PMID:18424601 DOI:10.1093/jn/138.5.914]
12 Raubenheimer PJ,Nyirenda MJ,Walker BR.A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet.Diabetes 2006;55:2015-2020[PMID:16804070 DOI:10.2337/db06-0097]
13 Gao X,Wang Y,Sun G.High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population.Nutrition 2017;33:28-34[PMID:27908547 DOI:10.1016/j.nut.2016.08.005]
14 Roe AJ,Zhang S,Bhadelia RA,Johnson EJ,Lichtenstein AH,Rogers GT,Rosenberg IH,Smith CE,Zeisel SH,Scott TM.Choline and its metabolites are differently associated with cardiometabolic risk factors,history of cardiovascular disease,and MRI-documented cerebrovascular disease in older adults.Am J Clin Nutr 2017;105:1283-1290[PMID:28356272DOI:10.3945/ajcn.116.137158]
15 Panchal SK,Poudyal H,Ward LC,Waanders J,Brown L.Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats.Food Funct 2015;6:2496-2506[PMID:26190559 DOI:10.1039/c5fo00480b]
16 Lee BJ,Lin JS,Lin YC,Lin PT.Antiinflammatory effects of L-carnitine supplementation(1000mg/d)in coronary artery disease patients.Nutrition 2015;31:475-479[PMID:25701337 DOI:10.1016/j.nut.2014.10.001]
17 Johri AM,Heyland DK,Hétu MF,Crawford B,Spence JD.Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease:evidence and controversies.Nutr Metab Cardiovasc Dis 2014;24:808-814[PMID:24837277 DOI:10.1016/j.numecd.2014.03.007]
18 Auinger A,Rubin D,Sabandal M,Helwig U,Rüther A,Schreiber S,Foelsch UR,D?ring F,Schrezenmeir J.A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome.Br J Nutr 2013;109:810-815[PMID:22809552 DOI:10.1017/S0007114512002656]
19 Cuturic M,Abramson RK,Breen RJ,Edwards AC,Levy EE.Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia:A cross-sectional study.World J Biol Psychiatry 2016;17:475-479[PMID:27088656 DOI:10.1080/15622975.2016.1178803]
20 Festi D,Schiumerini R,Eusebi LH,Marasco G,Taddia M,Colecchia A.Gut microbiota and metabolic syndrome.World J Gastroenterol 2014;20:16079-16094[PMID:25473159 DOI:10.3748/wjg.v20.i43.16079]
21 Tang WH,Hazen SL.Microbiome,trimethylamine N-oxide,and cardiometabolic disease.Transl Res 2017;179:108-115[PMID:27490453 DOI:10.1016/j.trsl.2016.07.007]
22 Mueller DM,Allenspach M,Othman A,Saely CH,Muendlein A,Vonbank A,Drexel H,von Eckardstein A.Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.Atherosclerosis 2015;243:638-644[PMID:26554714 DOI:10.1016/j.atherosclerosis.2015.10.091]
23 Tr?seid M,Hov JR,Nestvold TK,Thoresen H,Berge RK,Svardal A,Lappeg?rd KT.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.Metab Syndr Relat Disord 2016;14:197-201[PMID:27081744 DOI:10.1089/met.2015.0120]
24 Barrea L,Annunziata G,Muscogiuri G,Di Somma C,Laudisio D,Maisto M,de Alteriis G,Tenore GC,Colao A,Savastano S.Trimethylamine-N-oxide(TMAO)as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome.Nutrients 2018;10:pii:E1971[PMID:30551613 DOI:10.3390/nu10121971]
25 Seldin MM,Meng Y,Qi H,Zhu W,Wang Z,Hazen SL,Lusis AJ,Shih DM.Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.J Am Heart Assoc 2016;5:pii:e002767[PMID:26903003 DOI:10.1161/JAHA.115.002767]
26 Sookoian S,Pirola CJ.Alanine and aspartate aminotransferase and glutamine-cycling pathway:their roles in pathogenesis of metabolic syndrome.World J Gastroenterol 2012;18:3775-3781[PMID:22876026 DOI:10.3748/wjg.v18.i29.3775]
27 Schindhelm RK,Dekker JM,Nijpels G,Stehouwer CD,Bouter LM,Heine RJ,Diamant M.Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women:the Hoorn Study.Diabet Med 2007;24:430-435[PMID:17388959 DOI:10.1111/j.1464-5491.2007.02100.x]
28 Olynyk JK,Knuiman MW,Divitini ML,Davis TM,Beilby J,Hung J.Serum alanine aminotransferase,metabolic syndrome,and cardiovascular disease in an Australian population.Am J Gastroenterol 2009;104:1715-1722[PMID:19491832 DOI:10.1038/ajg.2009.229]
29 Gonzalez-Franquesa A,Burkart AM,Isganaitis E,Patti ME.What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?Curr Diab Rep 2016;16:74[PMID:27319324 DOI:10.1007/s11892-016-0763-1]
30 Pallares-Méndez R,Aguilar-Salinas CA,Cruz-Bautista I,Del Bosque-Plata L.Metabolomics in diabetes,a review.Ann Med 2016;48:89-102[PMID:26883715 DOI:10.3109/07853890.2015.1137630]
31 Yamada J,Tomiyama H,Yambe M,Koji Y,Motobe K,Shiina K,Yamamoto Y,Yamashina A.Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.Atherosclerosis2006;189:198-205[PMID:16405892 DOI:10.1016/j.atherosclerosis.2005.11.036]
32 Cheng S,Rhee EP,Larson MG,Lewis GD,McCabe EL,Shen D,Palma MJ,Roberts LD,Dejam A,Souza AL,Deik AA,Magnusson M,Fox CS,O'Donnell CJ,Vasan RS,Melander O,Clish CB,Gerszten RE,Wang TJ.Metabolite profiling identifies pathways associated with metabolic risk in humans.Circulation 2012;125:2222-2231[PMID:22496159 DOI:10.1161/CIRCULATIONAHA.111.067827]
33 Wang TJ,Larson MG,Vasan RS,Cheng S,Rhee EP,McCabe E,Lewis GD,Fox CS,Jacques PF,Fernandez C,O'Donnell CJ,Carr SA,Mootha VK,Florez JC,Souza A,Melander O,Clish CB,Gerszten RE.Metabolite profiles and the risk of developing diabetes.Nat Med 2011;17:448-453[PMID:21423183 DOI:10.1038/nm.2307]
34 Wang S,Yu X,Zhang W,Ji F,Wang M,Yang R,Li H,Chen W,Dong J.Association of serum metabolites with impaired fasting glucose/diabetes and traditional risk factors for metabolic disease in Chinese adults.Clin Chim Acta 2018;487:60-65[PMID:30237081 DOI:10.1016/j.cca.2018.09.028]
35 Co?ffier M,Marion R,Leplingard A,Lerebours E,DucrottéP,Déchelotte P.Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e(2)production by human gut in-vitro.Cytokine 2002;18:92-97[PMID:12096924 DOI:10.1006/cyto.2002.1027]
36 Tulipani S,Palau-Rodriguez M,Mi?arro Alonso A,Cardona F,Marco-Ramell A,Zonja B,Lopez de Alda M,Mu?oz-Garach A,Sanchez-Pla A,Tinahones FJ,Andres-Lacueva C.Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes.Clin Chim Acta 2016;463:53-61[PMID:27720726 DOI:10.1016/j.cca.2016.10.005]
37 Newgard CB,An J,Bain JR,Muehlbauer MJ,Stevens RD,Lien LF,Haqq AM,Shah SH,Arlotto M,Slentz CA,Rochon J,Gallup D,Ilkayeva O,Wenner BR,Yancy WS,Eisenson H,Musante G,Surwit RS,Millington DS,Butler MD,Svetkey LP.A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.Cell Metab 2009;9:311-326[PMID:19356713 DOI:10.1016/j.cmet.2009.02.002]
38 RoyChoudhury S,Mishra BP,Khan T,Chattopadhayay R,Lodh I,Datta Ray C,Bose G,Sarkar HS,Srivastava S,Joshi MV,Chakravarty B,Chaudhury K.Serum metabolomics of Indian women with polycystic ovary syndrome using 1H NMR coupled with a pattern recognition approach.Mol Biosyst 2016;12:3407-3416[PMID:27714060 DOI:10.1039/c6mb00420b]
39 Shim K,Gulhar R,Jialal I.Exploratory Metabolomics of Nascent Metabolic Syndrome.J Diabetes Complications 2018;In press[DOI:10.1016/j.jdiacomp.2018.12.002]
40 Monti LD,Casiraghi MC,Setola E,Galluccio E,Pagani MA,Quaglia L,Bosi E,Piatti P.L-arginine enriched biscuits improve endothelial function and glucose metabolism:a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome.Metabolism 2013;62:255-264[PMID:23040413 DOI:10.1016/j.metabol.2012.08.004]
41 Deveaux A,Pham I,West SG,AndréE,Lantoine-Adam F,Bunouf P,Sadi S,Hermier D,MathéV,Fouillet H,Huneau JF,Benamouzig R,Mariotti F.l-Arginine Supplementation Alleviates Postprandial Endothelial Dysfunction When Baseline Fasting Plasma Arginine Concentration Is Low:A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors.J Nutr 2016;146:1330-1340[PMID:27281800 DOI:10.3945/jn.115.227959]
42 Kawano T,Nomura M,Nisikado A,Nakaya Y,Ito S.Supplementation of L-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats.Life Sci 2003;73:3017-3026[PMID:14519450 DOI:10.1016/j.lfs.2003.06.004]
43 Korish AA.Multiple antioxidants and L-arginine modulate inflammation and dyslipidemia in chronic renal failure rats.Ren Fail 2010;32:203-213[PMID:20199183 DOI:10.3109/08860221003592820]
44 Lucotti P,Monti L,Setola E,La Canna G,Castiglioni A,Rossodivita A,Pala MG,Formica F,Paolini G,Catapano AL,Bosi E,Alfieri O,Piatti P.Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.Metabolism 2009;58:1270-1276[PMID:19592054 DOI:10.1016/j.metabol.2009.03.029]
45 Lucotti P,Setola E,Monti LD,Galluccio E,Costa S,Sandoli EP,Fermo I,Rabaiotti G,Gatti R,Piatti P.Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese,insulin-resistant type 2 diabetic patients.Am J Physiol Endocrinol Metab 2006;291:E906-E912[PMID:16772327 DOI:10.1152/ajpendo.00002.2006]
46 Konukoglu D,Firtina S,Serin O.The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal,impaired,and diabetic glucose tolerance.Metabolism 2008;57:110-115[PMID:18078867 DOI:10.1016/j.metabol.2007.08.013]
47 Ganz T,Wainstein J,Gilad S,Limor R,Boaz M,Stern N.Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.Diabetes Metab Res Rev 2017;33[PMID:27393712 DOI:10.1002/dmrr.2836]
48 Du S,Sun S,Liu L,Zhang Q,Guo F,Li C,Feng R,Sun C.Effects of Histidine Supplementation on Global Serum and Urine 1H NMR-based Metabolomics and Serum Amino Acid Profiles in Obese Women from a Randomized Controlled Study.J Proteome Res 2017;16:2221-2230[PMID:28447460 DOI:10.1021/acs.jproteome.7b00030]
49 Mong MC,Chao CY,Yin MC.Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet.Eur J Pharmacol 2011;653:82-88[PMID:21167151 DOI:10.1016/j.ejphar.2010.12.001]
50 Hasegawa S,Ichiyama T,Sonaka I,Ohsaki A,Okada S,Wakiguchi H,Kudo K,Kittaka S,Hara M,Furukawa S.Cysteine,histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells.Clin Exp Immunol 2012;167:269-274[PMID:22236003 DOI:10.1111/j.1365-2249.2011.04519.x]
51 Watanabe M,Suliman ME,Qureshi AR,Garcia-Lopez E,Bárány P,Heimbürger O,Stenvinkel P,Lindholm B.Consequences of low plasma histidine in chronic kidney disease patients:associations with inflammation,oxidative stress,and mortality.Am J Clin Nutr 2008;87:1860-1866[PMID:18541578 DOI:10.1093/ajcn/87.6.1860]
52 Gralka E,Luchinat C,Tenori L,Ernst B,Thurnheer M,Schultes B.Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner.Am J Clin Nutr 2015;102:1313-1322[PMID:26581381 DOI:10.3945/ajcn.115.110536]
53 Feng RN,Niu YC,Sun XW,Li Q,Zhao C,Wang C,Guo FC,Sun CH,Li Y.Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome:a randomised controlled trial.Diabetologia 2013;56:985-994[PMID:23361591 DOI:10.1007/s00125-013-2839-7]
54 Han N,Chae JW,Jeon J,Lee J,Back HM,Song B,Kwon KI,Kim SK,Yun HY.Prediction of Methionine and Homocysteine levels in Zucker diabetic fatty(ZDF)rats as a T2DM animal model after consumption of a Methionine-rich diet.Nutr Metab(Lond)2018;15:14[PMID:29449868 DOI:10.1186/s12986-018-0247-1]
55 Adams SH.Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.Adv Nutr 2011;2:445-456[PMID:22332087 DOI:10.3945/an.111.000737]
56 Bene J,Márton M,Mohás M,Bagosi Z,Bujtor Z,Oroszlán T,Gasztonyi B,Wittmann I,Melegh B.Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome.Ann Nutr Metab 2013;62:80-85[PMID:23296094 DOI:10.1159/000345759]
57 Bremer AA,Mietus-Snyder M,Lustig RH.Toward a unifying hypothesis of metabolic syndrome.Pediatrics 2012;129:557-570[PMID:22351884 DOI:10.1542/peds.2011-2912]
58 Mohorko N,Petelin A,Jurdana M,Biolo G,Jenko-Pra?nikar Z.Elevated serum levels of cysteine and tyrosine:early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome.Biomed Res Int 2015;2015:418681[PMID:25821801 DOI:10.1155/2015/418681]
59 Elshorbagy AK,Valdivia-Garcia M,Refsum H,Butte N.The Association of Cysteine with Obesity,Inflammatory Cytokines and Insulin Resistance in Hispanic Children and Adolescents.PloS One 2012;7:e44166[PMID:22984471 DOI:10.1371/journal.pone.0044166]
60 Martínez Y,Li X,Liu G,Bin P,Yan W,Más D,ValdiviéM,Hu CA,Ren W,Yin Y.The role of methionine on metabolism,oxidative stress,and diseases.Amino Acids 2017;49:2091-2098[PMID:28929442 DOI:10.1007/s00726-017-2494-2]
61 Iida M,Harada S,Kurihara A,Fukai K,Kuwabara K,Sugiyama D,Takeuchi A,Okamura T,Akiyama M,Nishiwaki Y,Suzuki A,Hirayama A,Sugimoto M,Soga T,Tomita M,Banno K,Aoki D,Takebayashi T.Profiling of plasma metabolites in postmenopausal women with metabolic syndrome.Menopause 2016;23:749-758[PMID:27070805 DOI:10.1097/GME.0000000000000630]
62 Iyer A,Fairlie DP,Brown L.Lysine acetylation in obesity,diabetes and metabolic disease.Immunol Cell Biol 2012;90:39-46[PMID:22083525 DOI:10.1038/icb.2011.99]
63 Messina V.Nutritional and health benefits of dried beans.Am J Clin Nutr 2014;100 Suppl 1:437S-442S[PMID:24871476 DOI:10.3945/ajcn.113.071472]
64 Hart LM,Vogelzangs N,Mook-Kanamori DO,Brahimaj A,Nano J,van der Heijden AAWA,Willems van Dijk K,Slieker RC,Steyerberg EW,Ikram MA,Beekman M,Boomsma DI,van Duijn CM,Slagboom PE,Stehouwer CDA,Schalkwijk CG,Arts ICW,Dekker JM,Dehghan A,Muka T,van der Kallen CJH,Nijpels G,van Greevenbroek MMJ.Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes.J Clin Endocrinol Metab 2018;103:4569-4579[PMID:30113659 DOI:10.1210/jc.2018-01165]
65 Cole LK,Vance JE,Vance DE.Phosphatidylcholine biosynthesis and lipoprotein metabolism.Biochim Biophys Acta 2012;1821:754-761[PMID:21979151 DOI:10.1016/j.bbalip.2011.09.009]
66 Burrill JS,Long EK,Reilly B,Deng Y,Armitage IM,Scherer PE,Bernlohr DA.Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes.Mol Endocrinol 2015;29:411-420[PMID:25635940 DOI:10.1210/me.2014-1275]
67 Riddle ES,Roman H,Ahsan M,Shin H,Thalacker-Mercer A.Leucine in the Presence of Inflammation Alters BCAA Metabolism in Human Myotubes.FASEB J 2016;30:Abstract 430.7
68 Fiehn O,Garvey WT,Newman JW,Lok KH,Hoppel CL,Adams SH.Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese AfricanAmerican women.PLoS One 2010;5:e15234[PMID:21170321 DOI:10.1371/journal.pone.0015234]
69 Hu W,Sun L,Gong Y,Zhou Y,Yang P,Ye Z,Fu J,Huang A,Fu Z,Yu W,Zhao Y,Yang T,Zhou H.Relationship between Branched-Chain Amino Acids,Metabolic Syndrome,and Cardiovascular Risk Profile in a Chinese Population:A Cross-Sectional Study.Int J Endocrinol2016;2016:8173905[PMID:27528871 DOI:10.1155/2016/8173905]
70 Newgard CB.Interplay between lipids and branched-chain amino acids in development of insulin resistance.Cell Metab 2012;15:606-614[PMID:22560213 DOI:10.1016/j.cmet.2012.01.024]
71 Libert DM,Nowacki AS,Natowicz MR.Metabolomic analysis of obesity,metabolic syndrome,and type 2 diabetes:amino acid and acylcarnitine levels change along a spectrum of metabolic wellness.PeerJ 2018;6:e5410[PMID:30186675 DOI:10.7717/peerj.5410]
72 Würtz P,Soininen P,Kangas AJ,R?nnemaa T,Lehtim?ki T,K?h?nen M,Viikari JS,Raitakari OT,Ala-Korpela M.Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults.Diabetes Care 2013;36:648-655[PMID:23129134 DOI:10.2337/dc12-0895]
73 Wijekoon EP,Skinner C,Brosnan ME,Brosnan JT.Amino acid metabolism in the Zucker diabetic fatty rat:effects of insulin resistance and of type 2 diabetes.Can J Physiol Pharmacol 2004;82:506-514[PMID:15389298 DOI:10.1139/y04-067]
74 Chen T,Zheng X,Ma X,Bao Y,Ni Y,Hu C,Rajani C,Huang F,Zhao A,Jia W,Jia W.Tryptophan Predicts the Risk for Future Type 2 Diabetes.PLoS One 2016;11:e0162192[PMID:27598004 DOI:10.1371/journal.pone.0162192]
75 Oxenkrug G,van der Hart M,Summergrad P.Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus.Integr Mol Med 2015;2:365-368[PMID:26523229 DOI:10.15761/IMM.1000169]
76 Reginaldo C,Jacques P,Scott T,Oxenkrug G,Selhub J,Paul L.Xanthurenic acid is associated with higher insulin resistance and higher odds of diabetes.FASEB J 2015;29:Abstract 919.20
77 Cervenka I,Agudelo LZ,Ruas JL.Kynurenines:Tryptophan's metabolites in exercise,inflammation,and mental health.Science 2017;357:pii:eaaf9794[PMID:28751584 DOI:10.1126/science.aaf9794]
78 Weinberg JM.Lipotoxicity.Kidney Int 2006;70:1560-1566[PMID:16955100 DOI:10.1038/sj.ki.5001834]
79 Suvitaival T,Bondia-Pons I,Yetukuri L,P?h?P,Nolan JJ,Hy?tyl?inen T,Kuusisto J,Ore?i?M.Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.Metabolism 2018;78:1-12[PMID:28941595 DOI:10.1016/j.metabol.2017.08.014]
80 Alshehry ZH,Mundra PA,Barlow CK,Mellett NA,Wong G,McConville MJ,Simes J,Tonkin AM,Sullivan DR,Barnes EH,Nestel PJ,Kingwell BA,Marre M,Neal B,Poulter NR,Rodgers A,Williams B,Zoungas S,Hillis GS,Chalmers J,Woodward M,Meikle PJ.Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type2 Diabetes Mellitus.Circulation 2016;134:1637-1650[PMID:27756783 DOI:10.1161/CIRCULA-TIONAHA.116.023233]
81 Pujos-Guillot E,Brandolini M,Pétéra M,Grissa D,Joly C,Lyan B,Herqueloté,Czernichow S,Zins M,Goldberg M,Comte B.Systems Metabolomics for Prediction of Metabolic Syndrome.JProteome Res 2017;16:2262-2272[PMID:28440083 DOI:10.1021/acs.jproteome.7b00116]